Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2000-5-8
pubmed:abstractText
We have previously shown that the gold-containing disease-modifying anti-rheumatic drugs, auranofin (AF) and gold sodium aurothiomalate (GSTM) reduce human umbilical vein endothelial cell (HUVEC) adhesion molecule expression and neutrophil (PMN) adherence. AF diminishes E-selectin and intercellular adhesion molecule-1 (ICAM-1) on cytokine-activated HUVEC, while GSTM decreases only E-selectin. Since tight adhesion is critical for PMN to damage EC, we tested whether these drugs modulated human PMN-mediated injury to TNF-alpha-activated HUVEC in vitro (as measured by 51Cr release). Here we show that TNF-alpha caused a prominent PMN-mediated cytotoxicity that was dose-dependently reduced when AF and GSTM were added to the assay system. We also found that a potent inhibitor of NF-kappaB, pyrrolidine dithiocarbamate (PDTC) in a dose-dependent manner impaired TNF-alpha-induced cytotoxicity, indicating a role of NF-kappaB activation in cytokine-induced endothelial injury. To examine the effects of AF and GSTM on TNF-alpha-induced NF-kappaB activation this was measured in HUVEC nuclear extracts by an electrophoretic mobility shift assay. AF, but not GSTM, decreased TNF-alpha-induced NF-kappaB activation in HUVEC. Thus, in this in vitro model of vasculitis, AF and GSTM dose dependently reduced TNF-alpha-mediated neutrophil-dependent cytotoxicity for HUVEC, and AF, but not GSTM, inhibited NF-kappaB mobilization, thereby providing possible mechanisms for effects of AF and GSTM.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-10331077, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-10381184, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-1722512, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-1841047, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-1969919, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-2112196, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-2677047, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-2991400, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-3091258, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-6321596, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-6407101, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-6813491, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-6828386, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7507507, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7522621, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7542214, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7545393, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7569976, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7585518, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7739562, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7775482, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7867060, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7890047, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-7991551, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8011280, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8052854, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8146594, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8353285, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8371761, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8413215, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8424450, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8497253, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8615853, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8621937, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8642242, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-8960638, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-9218611, http://linkedlifedata.com/resource/pubmed/commentcorrection/10759767-9973188
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
79-84
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Effects of anti-rheumatic gold salts on NF-kappa B mobilization and tumour necrosis factor-alpha (TNF-alpha)-induced neutrophil-dependent cytotoxicity for human endothelial cells.
pubmed:affiliation
Departments of Rheumatology and Haematology,The Karolinska Institute, Huddinge University Hospital, Huddinge, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't